Capricor Therapeutics Statistics Share Statistics Capricor Therapeutics has 45.71M
shares outstanding. The number of shares has increased by 40.47%
in one year.
Shares Outstanding 45.71M Shares Change (YoY) 40.47% Shares Change (QoQ) 0.07% Owned by Institutions (%) 41.16% Shares Floating 40.15M Failed to Deliver (FTD) Shares 61,582 FTD / Avg. Volume 2.16%
Short Selling Information The latest short interest is 9.8M, so 21.44% of the outstanding
shares have been sold short.
Short Interest 9.8M Short % of Shares Out 21.44% Short % of Float 24.4% Short Ratio (days to cover) 2.88
Valuation Ratios The PE ratio is -12.01 and the forward
PE ratio is -19.37.
Capricor Therapeutics's PEG ratio is
-0.31.
PE Ratio -12.01 Forward PE -19.37 PS Ratio 21.82 Forward PS 3 PB Ratio 3.34 P/FCF Ratio -11.7 PEG Ratio -0.31
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Capricor Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.77,
with a Debt / Equity ratio of 0.01.
Current Ratio 7.77 Quick Ratio 7.77 Debt / Equity 0.01 Debt / EBITDA -0.04 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $139.19K Profits Per Employee $-252.92K Employee Count 160 Asset Turnover 0.13 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 99.49% in the
last 52 weeks. The beta is 0.59, so Capricor Therapeutics's
price volatility has been higher than the market average.
Beta 0.59 52-Week Price Change 99.49% 50-Day Moving Average 9.56 200-Day Moving Average 12.89 Relative Strength Index (RSI) 56.72 Average Volume (20 Days) 2,857,564
Income Statement In the last 12 months, Capricor Therapeutics had revenue of 22.27M
and earned -40.47M
in profits. Earnings per share was -1.15.
Revenue 22.27M Gross Profit 20.84M Operating Income -42.56M Net Income -40.47M EBITDA -41.14M EBIT -42.56M Earnings Per Share (EPS) -1.15
Full Income Statement Balance Sheet The company has 11.29M in cash and 1.45M in
debt, giving a net cash position of 9.84M.
Cash & Cash Equivalents 11.29M Total Debt 1.45M Net Cash 9.84M Retained Earnings -199.83M Total Assets 153.77M Working Capital 123.91M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -40M
and capital expenditures -1.54M, giving a free cash flow of -41.53M.
Operating Cash Flow -40M Capital Expenditures -1.54M Free Cash Flow -41.53M FCF Per Share -1.18
Full Cash Flow Statement Margins Gross margin is 93.6%, with operating and profit margins of -191.13% and -181.71%.
Gross Margin 93.6% Operating Margin -191.13% Pretax Margin -181.71% Profit Margin -181.71% EBITDA Margin -184.73% EBIT Margin -191.13% FCF Margin -186.51%
Dividends & Yields CAPR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CAPR is $24.5,
which is 213.3% higher than the current price. The consensus rating is "Buy".
Price Target $24.5 Price Target Difference 213.3% Analyst Consensus Buy Analyst Count 8
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 5, 2019. It was a
backward
split with a ratio of 1:10.
Last Split Date Jun 5, 2019 Split Type backward Split Ratio 1:10
Scores Altman Z-Score 6.28 Piotroski F-Score 2
